NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

George R.R. Martin is writing NWBO’s journal article.

That's one possibility. Another is that they are just plain refusing to release the data because it's not good and they know it. In fact, they've known it for six years.

Changing the endpoints did not fix the problems with this trial, nor did the decision to use historical comps. Those who haven't been here very long have no perspective, but those of us who have seen this "silent treatment" behavior so many times in the past know what is up. Dr. Linda Liau knows what is up. And the market seems to know, as well, that we are getting close to the final rug pull.